Status:

COMPLETED

Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy

Lead Sponsor:

Ospedale Misericordia e Dolce

Conditions:

Contrast-Induced Nephropathy

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

Contrast-induced nephrophaty (CIN) accounts for more than 10% of hospital-acquired renal failure. Hydration with sodium bicarbonate is more protective than isotonic saline in animals. Limited data are...

Eligibility Criteria

Inclusion

  • patients with creatinine clearance \< 60 mL/min

Exclusion

  • contrast medium administration within the previous 10 days
  • end-stage renal failure requiring dialysis
  • refusal to give informed consent

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2006

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT00606827

Start Date

January 1 2005

End Date

March 1 2006

Last Update

May 8 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ospedale Misericordia e Dolce

Prato, Prato, Italy, 59100

Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy | DecenTrialz